Defective CYP26C1 causes FFDD4

Stable Identifier
Homo sapiens
Defective CYP26C1 causes Focal facial dermal dysplasia 4 (FFDD4)
Locations in the PathwayBrowser
SVG |   | PPTX  | SBGN
Click the image above or here to open this pathway in the Pathway Browser

Retinoic acid (RA) is a biologically active analogue of vitamin A (retinol). RA plays an important role in regulating cell growth and differentiation. CYP26C1 is involved in the metabolic breakdown of RA by 4-hydroxylation. While CYP26C1 can hydroxylate the trans form, it is unique in hydroxylating the 9-cis isomer of RA (9cRA) (Taimi et al. 2004). Defects in CYP26C1 can cause focal facial dermal dysplasia 4 (FFDD4; MIM:614974), a rare syndrome characterised by facial lesions.

Literature References
PubMed ID Title Journal Year
23161670 Focal facial dermal dysplasia, type IV, is caused by mutations in CYP26C1

Tang, PL, Petkovich, M, Lao, R, Chu, C, Yahyavi, M, Nazarenko, I, Mehrotra, P, Frieden, I, Prescott, T, Devriendt, K, Morren, MA, Cordoro, K, Marqueling, AL, Chou, C, Kwok, PY, Slavotinek, AM, Cameron, D, Li, B, Desnick, RJ, Glaser, T

Hum. Mol. Genet. 2013
14532297 A novel human cytochrome P450, CYP26C1, involved in metabolism of 9-cis and all-trans isomers of retinoic acid

White, J, Taimi, M, Helvig, C, Petkovich, M, Ramshaw, H, Korczak, B, Amad, M, Wisniewski, J

J Biol Chem 2004
Name Identifier Synonyms
skin benign neoplasm DOID:3165 neoplasm of skin (disorder), tumor of the skin, neoplasm of skin by site, skin neoplasm
Cite Us!